Figure 1From: Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collectionVenn diagram of numbers of haploinsufficient and haploproficient genes after removal of bad tags and dubious ORFs. Haploinsufficient genes are often shared between all three drug conditions; genes involved in heat shock response show a similar phenotype. IBA and ALE appear to have an overlapping mode of action on genes associated with secondary N-BP targets, such as chromatin structure, but not on primary, mevalonate-dependent interactions, while RIS and IBA share the main N-BP target, the farnesyl transferase ERG20, part of the mevalonate pathway.Back to article page